UK medtech industry sees opportunities in NHS’s ‘forward view’
This article was originally published in Clinica
Executive Summary
The NHS Five Year Forward View (5YFV), released last week by NHS England chief executive Simon Stevens, is in some ways an outcomes-focused grand vision of how care should be delivered through NHS England’s multiple and various structures.
You may also be interested in...
UK Viewpoint: Tech & Innovation In Focus In NHS Chief's 'Forward View'
Filtering out the background noise, NHS England's chief executive tends to give a straightforward account of the state and the needs of the national health care provider. He did just that in a mid-term update of the NHS Five Year Forward View on March 31.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.